EcoR1 Capital LLC 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:43 pm Sale | 2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital LLC | 3,223,851 2.900% | -2,394,928 (-42.62%) | Filing |
| 2024-02-14 5:37 pm Purchase | 2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital LLC | 5,618,779 5.800% | 386,500 (+7.39%) | Filing |
| 2022-11-23 12:28 pm Purchase | 2022-11-14 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital LLC | 5,232,279 5.500% | 5,232,279 (New Position) | Filing |